Burcon’s Peazazz and Peazac Pea Proteins Receive Self-Affirmed GRAS Status
2018年6月18日 - 9:14PM
Burcon NutraScience Corporation (TSX:BU) (“Burcon” or the
“Company”) a leader in natural product extraction, purification and
isolation technologies, is pleased to announce the Company’s
Peazazz® and Peazac® pea proteins have received self-affirmed
Generally Recognized As Safe (GRAS) status, and the Company has
officially submitted to the United States Food and Drug
Administration (“FDA”) a formal GRAS Notification dossier.
Burcon engaged experts to proactively gather and provide the
scientific evidence necessary to affirm this important FDA
designation recognizing Burcon’s Peazazz® and Peazac® pea proteins
as safe.
Obtaining GRAS status is important for the acceptance and use of
these protein ingredients by leading food and beverage
companies. GRAS status removes regulatory barriers for food
innovators, ingredient buyers, and mass-market food service buyers
to use Burcon’s Peazazz® and Peazac™ pea proteins in their product
offerings. The demand for pea protein is expanding rapidly and is
now an in-demand ingredient for fast growing specialty food
companies, as well as large-scale multinational consumer-packaged
goods (CPG) companies seeking to respond to consumer demand for
more natural, and high-nutrition products.
For a substance to be considered GRAS, scientific data and
information about the intended use of the substance must be widely
known and there must be a consensus among qualified experts that
the data and information establish the substance is safe under the
conditions of its intended use. GRAS status is the standard
set by the US FDA for food ingredients to be accepted for use in
foods and beverages. With today’s announcement, Burcon’s
Peazazz® and Peazac® are officially affirmed GRAS. Burcon has
chosen to also pursue GRAS Notification for Peazazz® and
Peazac®. GRAS Notification is an additional voluntary
procedure whereby a company informs the FDA of its determination
that the use of a substance is GRAS. A substance is GRAS
notified when, after reviewing the GRAS notification, the FDA
responds with a no-objection letter indicating that it is satisfied
with the submission. As announced today, Burcon has
officially submitted to the FDA a formal GRAS notification dossier
for Peazazz® and Peazac™ pea proteins. It is important to
note however that Burcon’s Peazazz® and Peazac® pea proteins are
considered GRAS from today’s date for their intended
applications.
Consumer demand for great-tasting, nutrient-dense foods is at an
all-time high and Burcon is committed to bringing its novel pea
protein ingredients to global markets.
Burcon is a pioneer in the development of novel plant-based
protein ingredients and has developed technologies for the
production of value added proteins from a variety of plant-based
sources including: soy; pulses (including pea); canola; hemp and
flax, to name a few.
Pea offers important advantages to consumers, and to farmers as
its production is environmentally friendly while being a great
source of protein, with numerous applications in dairy-free foods,
vegetarian foods, sports and slimming foods, senior nutrition and
clinical nutrition. Burcon’s Peazazz® pea protein has
uniquely clean flavor characteristics and exceptional solubility
and is well-suited for use in beverages, dairy alternative
products, meal replacements as well as a variety of other healthy
and great tasting food and beverage product applications.
“Today’s announcement marks an important milestone in the
development of Burcon’s novel pea proteins Peazazz and Peazac,”
said Johann Tergesen, Burcon’s president and chief operating
officer, adding, “We are looking forward to offering our novel pea
protein products to customers and consumers in Canada, North
America and worldwide.”
About Burcon NutraScience Corporation
Burcon is a leader in developing technologies for the production
of valuable plant-sourced ingredients for use in food, nutrition,
wellness and supplement products. The company has developed a
portfolio of composition, application, and process patents
originating from a core protein extraction and purification
technology. Burcon’s CLARISOY® soy protein offers clarity and
high-quality protein nutrition for low pH beverage systems and
excellent solubility and exceptionally clean flavor at any pH;
Peazazz® is a uniquely soluble and clean-tasting pea protein; and
Puratein®, Supertein® and Nutratein® are canola protein isolates
with unique functional and nutritional attributes. Burcon is
also conducting research to develop extraction and isolation
processes for the production of purified cannabinoid extracts from
cannabis and other organic source materials. For more
information about the company, visit www.burcon.ca.
The TSX has not reviewed and does not accept
responsibility for the adequacy of the content of the information
contained herein. This press release contains forward-looking
statements or forward-looking information within the meaning of the
U.S. Private Securities Litigation Reform Act of 1995 and
applicable Canadian securities legislation. Forward-looking
statements or forward-looking information involve risks,
uncertainties and other factors that could cause actual results,
performances, prospects and opportunities to differ materially from
those expressed or implied by such forward-looking statements.
Forward- looking statements or forward-looking information can be
identified by words such as “anticipate,” “intend,” “plan,” “goal,”
“project,” “estimate,” “expect,” “believe”, “future,” “likely,”
“may,” “should,” “could”, “will” and similar references to future
periods. All statements other than statements of historical fact
included in this release are forward-looking statements, including,
without limitation, statements regarding expectations, intentions
and plans contained in this press release. There can be no
assurance that such statements will prove to be accurate and actual
results and future events could differ materially from those
anticipated in such statements or information. Important factors
that could cause actual results to differ materially from Burcon’s
plans and expectations include the actual results of business
negotiations, marketing activities, adverse general economic,
market or business conditions, regulatory changes and other risks
and factors detailed herein and from time to time in the filings
made by Burcon with securities regulators and stock exchanges,
including in the section entitled “Risk Factors” in Burcon’s annual
information form dated June 21, 2017 filed with the Canadian
securities administrators on www.sedar.com. Any
forward-looking statement or information only speaks as of the date
on which it was made and, except as may be required by applicable
securities laws, Burcon disclaims any intent or obligation to
update any forward-looking statement, whether as a result of new
information, future events or otherwise. Although Burcon believes
that the assumptions inherent in the forward-looking statements are
reasonable, forward-looking statements are not guarantees of future
performance, and accordingly, investors should not rely on such
statements.
CLARISOY is a trademark of Archer Daniels
Midland Company.
Media & Industry Contact:Paul LamManager,
Business DevelopmentBurcon NutraScience CorporationTel (604)
733-0896, Toll-free (888) 408-7960plam@burcon.ca
www.burcon.ca
Burcon NutraScience (TSX:BU)
過去 株価チャート
から 11 2024 まで 12 2024
Burcon NutraScience (TSX:BU)
過去 株価チャート
から 12 2023 まで 12 2024